Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study.
Tancredi S, Chiolero A, Wagner C, Haller M, Chocano-Bedoya P, Ortega N, Rodondi N, Kaufmann L, Lorthe E, Baysson H, Stringhini S, Michel G, Luedi C, Harju E, Frank I, Imboden M, Witzig M, Keidel D, Probst-Hensch N, Amati R, Albanese E, Corna L, Crivelli L, Vincentini J, Nusslé S, Bochud M, d'Acremont V, Kohler P, Kahlert C, Cusini A, Frei A, Puhan M, Geigges M, Kaufmann M, Fehr J, Cullati S, Corona Immunitas Research Group. Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study. Infection 2023; 51:1453-1465.
04.03.2023
Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study.
04.03.2023
Infection 2023; 51:1453-1465
Tancredi Stefano, Chiolero Arnaud, Wagner Cornelia, Haller Moa Lina, Chocano-Bedoya Patricia O, Ortega Natalia, Rodondi Nicolas, Kaufmann Laurent, Lorthe Elsa, Baysson Hélène, Stringhini Silvia, Michel Gisela, Luedi Chantal, Harju Erika, Frank Irène, Imboden Medea, Witzig Melissa, Keidel Dirk, Probst-Hensch Nicole M, Amati Rebecca, Albanese Emiliano, Corna Laurie, Crivelli Luca, Vincentini Julia, Nusslé Semira Gonseth, Bochud Murielle, d'Acremont Valérie, Kohler Philipp, Kahlert Christian, Cusini Alexia, Frei Anja, Puhan Milo Alan, Geigges Marco, Kaufmann Marco, Fehr Jan S, Cullati Stéphane, Corona Immunitas Research Group
Weiter
